New Zealand's benchmark equity index eked out a modest gain on Wednesday, as gains in healthcare and utility stocks offset weakness in travel, retail, and dairy shares. The S&P/NZX 50 rose 5.90 points, or 0.05%, to close at 12,770.30, recovering from a 0.86% decline in the prior session.
Trading volume reached 28.78 million shares, with the index fluctuating between an intraday low of 12,726.35 and a high of 12,783.97. The market's defensive tone was evident, with investors focusing on inflation signals from the Reserve Bank of New Zealand (RBNZ), U.S. megacap earnings, and Federal Reserve developments.
Fisher & Paykel Healthcare Leads Gains
Fisher & Paykel Healthcare was the standout performer, advancing 1.48% to NZ$36.25. The stock saw NZ$16.7 million in turnover, providing significant support to the index. According to Peter McIntyre, investment adviser at Craigs Investment Partners, the market would have been notably weaker without Fisher & Paykel's contribution.
Utility Stocks Shine
Power stocks also attracted buying interest. Contact Energy rose 1% to NZ$9.32, Meridian Energy edged up 0.4% to NZ$5.55, Mercury NZ gained 0.6% to NZ$6.71, and Genesis Energy finished 0.4% higher at NZ$2.39. The healthcare sector advanced 0.84%, while utilities added 0.63%, providing a solid base for the index.
Fletcher Building Gains on Analyst Upgrade
Fletcher Building climbed 1.1% to NZ$2.81 after Forsyth Barr maintained its “outperform” rating and NZ$3.80 price target. The positive sentiment followed the company’s decision to sell its Fletcher Reinforcing and Wire business to United Industries for NZ$15.7 million. Fletcher expects a loss on the sale of between NZ$20 million and NZ$23 million once the transaction closes.
Travel and Retail Stocks Struggle
Travel stocks faced headwinds after Booking Holdings lowered its full-year revenue outlook, citing the ongoing conflict in the Middle East, which is expected to weigh on bookings through late June. KMD Brands tumbled 6.15% to 6.1 NZ cents, while Serko dropped 4.5% and Tourism Holdings fell 2.9%. Ryman Healthcare and NZX Ltd were also among the key laggards.
Dairy Sector Under Pressure
Dairy stocks weighed on the session. Fonterra Shareholders’ Fund declined 4.6% to NZ$6.40, a2 Milk slipped 1.8% to NZ$8.72, and Synlait Milk tumbled 7.8% to 41.5 NZ cents, marking the steepest decline among main board names.
Inflation and Monetary Policy in Focus
Investors remained attentive to inflation data after RBNZ Governor Anna Breman reported annual consumer price inflation of 3.1% in the March quarter, slightly above the central bank’s 1% to 3% target range. Core inflation measures, however, stayed within the band. On April 8, the RBNZ left its official cash rate unchanged at 2.25%, with Breman stating that policymakers are “ready to act decisively” if short-term price pressures persist.
Regional Markets Mixed
Across the Tasman, Australia’s S&P/ASX 200 slipped 0.3% in late trade, while Japan’s Nikkei 225 fell 1%. Hong Kong’s Hang Seng bucked the trend, advancing 1.4%. In Australia, first-quarter consumer prices surged, driven by higher energy costs linked to the Middle East conflict. Stephen Smith at Deloitte Access Economics described the data as pointing to a rate hike from the Reserve Bank of Australia next week.
Despite Wednesday’s green finish, the breadth of the NZX market was weak, with losers outpacing winners for much of the day. The index’s gains were largely concentrated in Fisher & Paykel Healthcare and a few defensive plays. Analysts caution that the index could face renewed pressure if Wall Street stumbles, central banks adopt a more hawkish stance, or travel disruptions deepen.
